These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 347110)

  • 21. Pimozide versus fluphenazine in ambulatory schizophrenics: A 12-month comparison study.
    Donlon PT; Swaback DO; Osborne ML
    Dis Nerv Syst; 1977 Feb; 38(2):119-23. PubMed ID: 319967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Fluphenazine with other antipsychotic drugs.
    Chouinard G; Fontaine R
    Am J Psychiatry; 1975 Jul; 132(7):760-1. PubMed ID: 1137032
    [No Abstract]   [Full Text] [Related]  

  • 23. Prediction of improvement in schizophrenia under four phenothiazines.
    Goldberg SC; Mattsson N; Cole JO; Klerman GL
    Arch Gen Psychiatry; 1967 Jan; 16(1):107-17. PubMed ID: 6066689
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate.
    Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR
    Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182
    [No Abstract]   [Full Text] [Related]  

  • 25. Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: preliminary findings.
    Steele C; Lucas MJ; Tune L
    J Clin Psychiatry; 1986 Jun; 47(6):310-2. PubMed ID: 3711028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A trial of fluphenazine enanthate in chronic schizophrenia.
    Millar J; Daniel GR
    Br J Psychiatry; 1967 Dec; 113(505):1431-2. PubMed ID: 4865296
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential effects of neuroleptic agents on the pituitary-gonadal axis in men.
    Brown WA; Laughren TP; Williams B
    Arch Gen Psychiatry; 1981 Nov; 38(11):1270-2. PubMed ID: 6118109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of some possible prognostic indicators of response to phenothiazine treatment of acute schizophrenic psychoses.
    Reznikoff M; Toomey LC
    Int J Neuropsychiatry; 1965 Aug; 1(4):352-8. PubMed ID: 4379396
    [No Abstract]   [Full Text] [Related]  

  • 29. EEG voltage as an indicator of drug-induced changes in schizophrenia.
    Bruck MA
    Am J Psychiatry; 1968 May; 124(11):1591-5. PubMed ID: 4869441
    [No Abstract]   [Full Text] [Related]  

  • 30. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients.
    Iqbal MJ; Young MA; Charles J; Elgart B; Von Greiff H; Simpson GM
    J Clin Psychiatry; 1978 Apr; 39(4):375-9. PubMed ID: 580285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of thioridazine and fluphenazine on the pituitary, thyroid and adrenal functions in patients with paranoid schizophrenia.
    Horodnicki JM; Czekalski S; Jarema M
    Psychiatr Pol; 1984; 18(3):205-11. PubMed ID: 6536002
    [No Abstract]   [Full Text] [Related]  

  • 33. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High doses of fluphenazine enanthate in schizophrenia. A controlled study.
    Dencker SJ; Johansson R; Lundin L; Malm U
    Acta Psychiatr Scand; 1978 May; 57(5):405-14. PubMed ID: 354329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fluphenazine dihydrochloride--a multicenter trial on 660 patients (author's transl)].
    Pieschl D; Kulhanek F; Piergies A
    Arzneimittelforschung; 1978; 28(9):1503-4. PubMed ID: 383100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thiothixene, thioridazine, and placebo in male chronic schizophrenic patients.
    Wolpert A; Sheppard C; Merlis S
    Clin Pharmacol Ther; 1968; 9(4):456-64. PubMed ID: 4871899
    [No Abstract]   [Full Text] [Related]  

  • 39. Factors related to tardive dyskinesia.
    Chouinard G; Annable L; Ross-Chouinard A; Nestoros JN
    Am J Psychiatry; 1979 Jan; 136(1):79-82. PubMed ID: 31802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacogenic depressive syndromes in the course of schizophrenic psychoses (author's transl)].
    Müller P; Kind J; Steuber H
    Arzneimittelforschung; 1978; 28(9):1501-2. PubMed ID: 383099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.